Stem Cells for Retinal & Eye Diseases: Restoring Vision

How stem cell therapy may restore vision in retinal diseases. RPE cell transplantation for macular degeneration, retinitis pigmentosa treatment, and clinical trial advances.

Stem Cell Therapy for Macular Degeneration and Retinal Disease

The retina is a prime target for cell therapy: it is immunologically privileged, well-accessible by subretinal and intravitreal injection, and retinal pigment epithelium (RPE) degeneration is the final common pathway for AMD, Stargardt disease, and other inherited retinal dystrophies. MSC therapy works via two mechanisms in retinal disease: paracrine neuroprotection (CNTF, PEDF, VEGF-trap secretion protecting photoreceptors and RPE from degeneration) and potential RPE differentiation (MSCs can be directed toward RPE-like phenotype in vitro and in some in vivo models).

Evidence in AMD, Stargardt, and Retinitis Pigmentosa

Clinical series from Iran (Weiss et al., Siqueira et al.) and multicentre trials report visual acuity stabilisation and in some cases modest improvement (1–3 ETDRS line gains) in dry AMD patients after intravitreal or subretinal MSC treatment. Retinitis pigmentosa series show ERG amplitude improvements and subjective visual field expansion in a subset. Stargardt disease (juvenile macular degeneration) early trials report VA stabilisation. Response is strongest when residual photoreceptor function exists; end-stage disease with complete outer retinal loss shows limited response.

Retinal Disease Treatment Protocol

StemCell Longevita's retinal programme delivers intravitreal and/or IV MSC therapy across 2–3 sessions, with ophthalmological evaluation (Snellen/ETDRS VA, OCT, Amsler grid, VEP) before and after treatment. Subretinal delivery (higher precision) requires specialist surgical facilities and is offered in select cases. Post-treatment retinal imaging at 3-month intervals monitors response and guides any repeat treatment decision.

Frequently Asked Questions

How does stem cell therapy reverse aging?

MSC therapy combats aging by replenishing the body's regenerative capacity, reducing chronic inflammation (inflammaging), improving cellular repair mechanisms, supporting telomere maintenance, and rejuvenating organ function at the cellular level.

What are the benefits of anti-aging stem cell therapy?

Benefits include improved skin elasticity and texture, increased energy levels, enhanced cognitive function, better sleep quality, improved immune function, reduced joint pain, and an overall sense of vitality and wellbeing.

How long do anti-aging stem cell therapy results last?

Most patients experience benefits lasting 12-18 months from a single treatment session. Many patients choose annual maintenance sessions to sustain and build upon their results over time.

What is the cost of anti-aging stem cell therapy in Istanbul?

Anti-aging stem cell therapy packages start from €6,950 at StemCell Longevita, including 30M+ MSCs, luxury hotel accommodation, VIP transfers, and comprehensive follow-up care. This is 50-85% less than comparable treatments in the US or Europe.

Related articles: Understanding Stem Cell Therapy (2026 Complete Guide) | Types of Stem Cells Explained (2026 Update) | Is Stem Cell Therapy Safe? Understanding Risks, Benefits & Evidence

Related treatments: Anti-Aging Stem Cell Therapy | Diabetes Stem Cell Therapy | Autoimmune Disease Stem Cell Therapy